Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs Inks Distribution Deals

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs said after the close of the market Tuesday that it has inked two new distribution agreements with Bioke and Imperial Life Sciences.

Bioke, a Dutch firm that sells reagents for signal transduction, cell culture, and molecular biology applications, serves markets in the Netherlands, Belgium, and Luxembourg. ILS supplies reagents for genomics, proteomics, cell biology, and imaging applications in India.

New England Biolabs said that it now has 39 companies worldwide in its distribution network.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.